Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women

Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Flavia Lillo(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Gianluca Taccagni, Davide Ferrari(University of Modena and Reggio Emilia), Franco Ameglio(Nuovo Ospedale San Giovanni di Dio), Augusto Ferrari(Vita-Salute San Raffaele University), S Reina(University of Genoa), Giulia Gallotta(Vita-Salute San Raffaele University), Maria Angela Grasso, Sara Lodini
AIDS
September 1, 2003
10.1097/00002030-200309260-00021
Cited by 19

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168